4 terminated. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
Follow Cross Infection: new trials by email Literature Review of Cross Infection trials Research Report on Cross Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia Ceftazidime-avibactam - Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia | Phase 1 | Terminated | Pfizer | 4 | 2020-06-15 | 2022-09-09 |
| Aerosolized and Intravenous Colistin in Healthy Adults Colistimethate sodium - Pathogen Resistance, Pneumococcal Infection | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 27 | 2013-08-06 | 2020-03-02 |
| Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia Ceftobiprole - Ventilator Associated Pneumonia | Phase 1 | Terminated | Basilea Pharmaceutica | 1 | 2008-10-01 | 2012-07-30 |
| Probiotic Enteral Administration in Mechanically Ventilated Patients Ergyphilus - Pneumonia | Phase 1 | Terminated | Central Hospital, Nancy, France | 740 | 2006-01-01 | 2010-09-24 |
Healthcare-Associated Pneumonia (2) · Pneumonia (2) · Pneumonia, Ventilator-Associated (2) · Pneumococcal Infections (1)
Disease Attributes (4) · Iatrogenic Disease (4) · Infections (4) · Lung Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Respiratory Tract Diseases (4) · Respiratory Tract Infections (4) · Healthcare-Associated Pneumonia (2) · Pneumonia (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Streptococcal Infections (1)
avibactam, ceftazidime drug combination (1) · ceftobiprole (1) · colistinmethanesulfonic acid (1)
Basilea Pharmaceutica (1) · Central Hospital, Nancy, France (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Pfizer (1)
China (1) · France (1) · Taiwan (1) · United States (1)
2018 (1)